Prophylactic Minimally Invasive Surfactant Evaluation
NCT06007547
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Respiratory Distress Syndrome, Newborn
- Premature Birth
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- Up to 15 Minutes
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Endeavor Health
- Last updated on ClinicalTrials.gov
- August 7, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Northshore University Healthsystem · Evanston, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.